If memory serves me, they went from 1,000 shares 6/30/2010 to over 5,000,000 at the recent Form 13 filing.
On MNTA stock movement. The stock is in a down trend. IF we have the fundamentals right there will be an inflection point. That could be soon or later this year. The inflection could be sudden, set off by an event or a slow curved bottoming process. The event could be one of many positives or the boggie-man Teva approval.
I am more interested in the long term than the ST, which has been somewhat perplexing. But then markets often defy logic as I see it.
It is amazing how long the FDA can take to act. The mL approval illustrates that as does the non-approval of a generic Vancocin. I can only wish that FDA behavior on tL.
ij
There are times when rules and precedents cannot be broken; others when they cannot be adhered to with safety. (Thomas Joplin)